AGAlessandro Gonfiotti

Alessandro Gonfiotti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alessandro Gonfiotti has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Injuries of the Posterior Tracheal Wall: Insights from a High-Volume Single-Centre Experience

    by Lavinia Gatteschi, Antonio Burlone, Stefano Bongiolatti, Simone Tombelli, Giovanni Mugnaini, Luca Voltolini, Alessandro Gonfiotti

    Background: Major airway injuries, regardless of whether their aetiology is traumatic or iatrogenic, are rare but potentially fatal. In selected cases, surgery plays a key role; however, it has to be performed by highly experienced professionals in emergency settings. Methods: We reviewed all surgical procedures involving the trachea which were performed at our institution in the last 5 years (365 procedures). We report here our experiences with major airway injuries, both traumatic and iatrogenic (19 procedures). All patients, including individuals from within our hospital and from other peripheral centres, were treated in an emergency setting within 12 h of correct diagnosis. Results: The location and extent of tracheal lesions can be different in every patient. After a proper evaluation with CT scan and bronchoscopy, we approached all our cases of tracheal injuries with a cervicotomy, using, in some selected cases, an endoscopic camera to better visualise lesions that involved the carina. However, in extremely severe cases, such as one we report here, where multiple repair attempts fail and tissue viability is compromised, demolitive surgery by means of posterolateral thoracotomy may represent the only remaining therapeutic option. Conclusions: Surgery on tracheal injuries is complex, highly specialised, and time-dependent. In selected cases, it has to be performed quickly by highly qualified professionals after proper evaluation in an emergency setting. Every airway injury differs in its location, extent, aetiology, and clinical presentation, and there is no unanimous consensus on standardising treatment. Only high-volume centres with highly experienced professionals can guarantee correct management of this rare but life-threatening event.


  • Open Access

    Rare massive thoracic metastasis of endometrial cancer: Chest wall demolition and reconstruction. A case report

    by Antonio Burlone, Simone Tombelli, Domenico Viggiano, Sara Borgianni, Alessandro Gonfiotti

    Introduction: Distant recurrences are a major problem after surgical treatment for endometrial carcinoma; metastases to the bone are usually restricted to the axial skeleton, cases of costal localization are few. We present a case of a massive costal metastases successfully treated in our department. Case presentation: A 60-year-old woman underwent bilateral hysteroannessectomy followed by adjuvant radiotherapy for endometrial adenocarcinoma pT3a FIGO IIIA. Follow-up was uneventful until an occasional chest x-ray was made: a lesion of 7,5 × 5,4 × 5,6 cm in dimension was found at the left sixth rib, compatible with endometrial origin after biopsy. Despite chemo and radiotherapy the lesion incremented in size showing no response to treatment: 20 × 22 × 22 cm. Once she came to our attention, surgical treatment was planned after multidisciplinary discussion: we performed a left ribs V-IX en-block resection with the mass. We restored the chest wall using a biological prothesis in association with 3 titanium rib bars. The chest wall defect was covered with a myocutaneous flap (latissimus dorsi, serratus anterior, pectoralis major and obliquus externus). Clinical discussion: bone metastases from endometrial carcinoma are reported with a mean diameter of 5 cm; in our report the huge lesion represents a high-risk scenario for post-operative complications. In this setting surgical resection with complex multimodality reconstruction is needed. Conclusions: This case is characterised by the rare localization and giant dimension of an endometrial metastasis. This report aims to describe the decision-making process, the successful demolition and reconstruction of the chest wall. Highlights:


  • Open Access

    Perioperative Anti-Fibrotic Treatment Prevents Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Lung Cancer Surgery

    by Stefano Bongiolatti, Alberto Salvicchi, Elisabetta Rosi, Elena Bargagli, Giovanni Mugnaini, Alessandro Gonfiotti, Federico Lavorini, Paolo Spagnolo, Andrea Dell’amore, Federico Rea, et al.

    Background: The surgical treatment of concomitant lung cancer in patients with idiopathic pulmonary fibrosis is challenging due to the risk of life-threatening complications such as acute exacerbation development in the perioperative period. Few studies have investigated the role of anti-fibrotic drugs in this setting. The aim of this multicenter retrospective study was to evaluate the incidence of acute exacerbation, according to Collard, after lung resection in patients affected by concomitant idiopathic pulmonary fibrosis and lung cancer who were or were not on antifibrotic treatment. Secondary outcomes included: 30 and 90-day mortality and an estimation of overall and disease-free survival. Material and Methods: The study population consisted of patients affected by idiopathic pulmonary fibrosis who received curative-intent lung surgery in three Italian academic centers between 2015 and 2022. Patients were divided into two groups based on whether they were on perioperative treatment with anti-fibrotic drugs (chronical or prophylactic use) or not. To define predictors of acute exacerbation, univariate and multivariable exact logistic regression analysis were performed. The Kaplan–Meier method with log-rank test was used to estimate survival. Results: During the study period, n = 55 patients underwent lung resection for lung cancer, including 29 patients who were treated with antifibrotic agents. Although the sample size was small and few events were studied, the incidence of acute exacerbation was significantly lower among patient on anti-fibrotic therapy (3.4% vs. 23.1%, p = 0.044); in addition, anti-fibrotic treatment was the strong factor preventing acute exacerbation at the multivariable analysis (OR 0.089, p = 0.038). Post-operative 30- and 90-day mortality rates were not significantly lower in the anti-fibrotic treatment group (0% and 0% vs. 7.7% and 11.5%, p = 0.21 and p = 0.099, respectively). Overall and disease-free survival rates were similar. Conclusions: Considering the limitations of this retrospective study with a small sample size, anti-fibrotic perioperative treatment was associated with reduced incidence of acute exacerbation. Based on these real-world data, this pathway could be proposed as a prophylactic treatment in patients with concomitant idiopathic pulmonary fibrosis and cancer undergoing lung resection.


  • Open Access

    Chest-Wall Tumors and Surgical Techniques: State-of-the-Art and Our Institutional Experience

    by Alessandro Gonfiotti, Alberto Salvicchi, Luca Voltolini

    The chest wall can be involved in both primary and secondary tumors, and even today, their management and treatment continue to be a challenge for surgeons. Primary chest-wall tumors are relatively rare and include a large group of neoplasms that can arise from not only bone or cartilage of the chest wall but also from associated subcutaneous tissue from muscle and blood vessels. Secondary tumors refer to a direct invasion of the chest wall by neoplasms located elsewhere in the body, mainly metastases from breast cancer and lung cancer. En-bloc surgical excision of the lesion should ensure adequate negative margins to avoid local recurrence, and a full thickness surgical resection is often required, and it can result in important chest-wall defects such as skeletal instability or impaired breathing dynamics. The reconstruction of large defects of the chest wall can be complex and often requires the use of prosthetic and biologic mesh materials. This article aims to review the literature on these tumor entities, focusing on the main surgical techniques and the most recent advances in chest-wall resection and reconstruction. We also report on the institutional experience our center.